
— POSITION PAPER
MILE & AVAYL join forces to pioneer the future of Medical Information with AI
AVAYL and MILE have entered into a strategic partnership to establish best practices for the successful and secure implementation of AI in scientific and highly regulated Medical Affairs workflows. Supported by leading global Medical Affairs associations, our position paper offers a comprehensive perspective on the field and will be discussed at major conferences.


— GET YOUR COPY
Download the Position Paper

A COLLABORATION BETWEEN



REVIEWED BY

— WHY WE WROTE IT
Purpose of the Position Paper
Deploying AI goes beyond technical adoption — it raises questions about organizational structure, quality standards and business value.
While AI promises to enhance workflows in Medical Affairs, its integration requires careful consideration. The collaboration between the Medical Information Leaders Europe Association (MILE) and AVAYL addresses these challenges.
The Position Paper offers practical guidance on integrating AI into Medical Affairs — focusing on strategies for selecting and implementing AI projects, maintaining quality and compliance during deployment, and building skills while managing organizational change.
The goal is to equip Medical Affairs professionals with the tools to turn AI’s promise into real impact.
— AUTHORS & CONTRIBUTORS
About the Authors

MILE, Medical Information Leaders in Europe, is an industry association founded in 2018. It works to share knowledge and best practice around the function of Medical Information (MI) in Europe, aiming to improve access to information about medicinal products for HCPs and patients.

MSLS, the Medical Science Liaison Society, is a 501(c)(3) non-profit organization exclusively dedicated to advancing the global MSL profession. The society serves as a voice for the profession by building awareness of the important contributions MSLs make in advancing science, ultimately improving the quality of life for patients, and provides resources, professional growth and development opportunities for the global MSL community.
.png)
AVAYL is a pioneering technology company driving innovation in Medical Affairs with AI-native workflow systems. Its core product, MedPro, empowers Medical Affairs teams by applying Artificial Intelligence in Medical Information workflows while following scientific principles and regulatory requirements. Trusted by leading life science companies, AVAYL helps manage the growing volume of medical evidence with speed and precision.